378 related articles for article (PubMed ID: 24974232)
1. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion versus bolus injection of loop diuretics for acute heart failure.
Rasoul D; Zhang J; Farnell E; Tsangarides AA; Chong SC; Fernando R; Zhou C; Ihsan M; Ahmed S; Lwin TS; Bateman J; Hill RA; Lip GY; Sankaranarayanan R
Cochrane Database Syst Rev; 2024 May; 5(5):CD014811. PubMed ID: 38775253
[TBL] [Abstract][Full Text] [Related]
4. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
[TBL] [Abstract][Full Text] [Related]
5. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
Allen LA; Turer AT; Dewald T; Stough WG; Cotter G; O'Connor CM
Am J Cardiol; 2010 Jun; 105(12):1794-7. PubMed ID: 20538132
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
Ng KT; Yap JLL
Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
8. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
Fudim M; Spates T; Sun JL; Kittipibul V; Testani JM; Starling RC; Tang WHW; Hernandez AF; Felker GM; O'Connor CM; Mentz RJ
Am Heart J; 2021 Sep; 239():110-119. PubMed ID: 34052212
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R
Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945
[TBL] [Abstract][Full Text] [Related]
10. Diuretic strategies in patients with acute decompensated heart failure.
Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
[TBL] [Abstract][Full Text] [Related]
11. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
[TBL] [Abstract][Full Text] [Related]
12. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
De Vecchis R; Baldi C; Di Biase G
Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
[TBL] [Abstract][Full Text] [Related]
13. Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.
Palazzuoli A; Pellegrini M; Franci B; Beltrami M; Ruocco G; Gonnelli S; Angelini GD; Nuti R
Intern Emerg Med; 2015 Feb; 10(1):41-9. PubMed ID: 25087085
[TBL] [Abstract][Full Text] [Related]
14. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH
J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538
[TBL] [Abstract][Full Text] [Related]
15. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
[TBL] [Abstract][Full Text] [Related]
17. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
18. Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.
Zheng Z; Jiang X; Chen J; He D; Xie X; Lu Y
ESC Heart Fail; 2021 Jun; 8(3):2070-2078. PubMed ID: 33689236
[TBL] [Abstract][Full Text] [Related]
19. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
20. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
